More Information

Submitted: 24 December 2019 | Approved: 30 December 2019 | Published: 31 December 2019

How to cite this article: Ogunkeyede SA, Adebola SO, Daniel A, Adeyemo AA. Burden of hearing loss in Subsaharan Africa: Snapshot from an ENT clinic in Nigeria. Heighpubs Otolaryngol Rhinol. 2019; 3: 001-005.

DOI: 10.29328/journal.hor.1001016

Copyright: © 2019 Ogunkeyede SA, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Disabling hearing loss; Communication; Developing country Health education; Rehabilitation

 FullText PDF

Burden of hearing loss in Subsaharan Africa: Snapshot from an ENT clinic in Nigeria

Ogunkeyede SA1,2*, Adebola SO3, Daniel A1,2 and Adeyemo AA4

1Department of Otorhinolaryngology, College of Medicine, University of Ibadan, Ibadan, Nigeria
2Department of Otorhinolaryngology, University College Hospital, Ibadan, Nigeria
3Department of Otorhinolaryngology Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso, Nigeria
4Institute of Childs Health, College of Medicine, University of Ibadan, Ibadan, Nigeria

*Address for Correspondence: Ogunkeyede SA, Department of Otorhinolaryngology, College of Medicine, University of Ibadan, Ibadan and University College Hospital, Ibadan, Nigeria, Tel: +2348033723634; Email: segunkeyede@yahoo.com

Background: Disabling hearing loss is a prevalent public health issue, with significant impact on patients’ communication. The disability associated with hearing loss depends on the severity of the hearing loss. There are limited rehabilitative measures in resource challenged environment. This study assesses the incidence, the factors for hearing impairment and the management outcome.

Methods: A descriptive three-year chart review of patients managed for hearing loss in a tertiary health center in a developing country. The data collected include demographic data, clinical presentation and risk factors for hearing loss, audiometric reports, rehabilitative measures and management outcome.

Results: The patients with ear symptoms managed within the study period were 1350, of whom 498 (36.8%) had hearing loss of varying degrees. These included 145 (29.1%) males and 353 (70.9%) females with male to female ratio of 1:2.4. The age ranged from 8 to 80 years (median age of 35.7). Disabling hearing loss in the better-hearing ear occurred in 216 (43.4%) of cases. Increasing age and chronic supportive otitis media were associated with disabling hearing loss. The hearing thresholds improved with hearing aids and ear surgical procedures; nonetheless the patients’ rehabilitation was impaired by limited resources.

Conclusion: There is poor rehabilitation of people with hearing loss, though management outcome is commendable in a few of them. Health education will reduce the risk factors for disabling hearing loss and improved rehabilitative measures are needed for these individuals.

Hearing loss is due to inadequacy of any part of the auditory system, from the pinna to the auditory cortex in the brain [1]. It is a continuum varying from undetectable degree of disability to a profound loss of hearing [2-4]. Hearing loss is the most prevalent sensory deficit worldwide [5]. The global prevalence of hearing loss is on the increase with two-thirds of these hearing impaired people residing in developing countries [6,7]. The global increase in hearing loss is partly due to increasing uncontrolled environmental noise exposure [8-10], the use of ototoxic medications in patients’ medical care [11] and increase in life expectancy with aging population in developed countries [12,13]. The hearing loss in developing countries is relatively fostered by lack of standard protocols for early detection and rehabilitation of hearing loss [14,15], and also by inadequate vaccination coverage against preventable viral agents implicated in hearing loss in the national immunization programme [16-18].

People with disabling hearing loss often have difficulty in interpreting speech sounds, which results in ineffective communication, delay in language acquisition, educational disadvantage, social isolation, stigmatization and poor quality of life [19-21]. Hearing rehabilitation are conservative or surgical measures that eliminate or reduce communication problems [22]. Surgical procedures eradicate ear diseases and restore hearing, while conservative hearing rehabilitation preserve the residual hearing and improve the hearing threshold with the use of hearing-aids or assistive listening devices. Captioning and sign language are valuable to those with severe hearing loss. However, the hearing-aid production has not meet global need and most amplification devices are available in industrialized economies while the majority of individuals with disabling hearing loss live in low- and middle-income countries [23]. Uptake of hearing aid in developing countries is influenced by the cost which is out of reach of patients and also by the post fixing maintenance services that is not readily available in the community [23]. The environmental risk factors for hearing loss such as noise exposure, ototoxic medications, head injury and ear infections can be controlled or prevented through health education. Immunization against infective agents such as rubella, mumps, and measles are primary preventive measures for hearing loss [18,24]. This clinical audit determines the incidence of disabling hearing loss and limitations in rehabilitating patients with hearing loss in a tertiary hospital in Southwestern Nigeria.

This is a 3-year (January 2015 to April 2018) descriptive chart review of patients with hearing loss managed at the Otorhinolaryngology clinic of Ladoke Akintola University of Technology Teaching Hospital, Ogbomosho, in a semi-urban community in Southwestern Nigeria. Institutional ethical approval (LTH/OGB/EC/2016/105) was obtained for the study. The hospital records of all patients that presented with hearing loss were retrieved and analysed, there was no missing record. The data on demographic characteristics, clinical presentation, risk factors and rehabilitative measures for hearing loss with treatment outcomes were extracted using a proforma. The diagnosis of hearing loss was made by consultant Otorhinolaryngologists after preliminary evaluation. The pure tone audiometry assessment was done using MAICO 53 diagnostic audiometer (UK), in a sound-proof booth. Pure-tone averages of hearing threshold levels (HTL’s) for the better ear (BE) and worse ear (WE) over four frequencies 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz were determined. Type of hearing loss was classified as Conductive, Sensorineural and Mixed [25]. The degree of hearing level was defined according to the World Health Organization classification system [4]. Hearing loss was categorized as conductive where air–bone gap was ≥ 15 dB [6]. In this study, disabling hearing loss was defined in children under the age of 15 years as a permanent unaided hearing threshold level in the better ear of 31 dB or greater” while the disabling hearing loss in adults refers to hearing loss of 40 dB or greater in the better hearing ear [4]. The data were analyzed using the IBM-Statistical Package for Social Sciences (IBM-SPSS version 20). The test of association was done using Chi-square and Fishers exact. p - values < 0.05 were set as statistically significant level at 95% confidence interval.

All patients with ear problems managed within the study period were 1350, of whom 498 patients had hearing loss. Disabling hearing loss in the better ear was observed in 216 (43.4%) patients (Table 1). The male to female ratio was 1:2.4 and the age ranged from 8 to 80 years (median age of 35.7 years). Disabling hearing loss was associated with advanced age (p = 0.001) with high occurrence in female population as shown in table 1. The degree of hearing loss varied among the patients; female patients were affected more than male patients both in adult and children populations as shown in table 2.

Table 1: Demographic characteristics of the patients.
Parameter Disabling hearing loss Total (n = 498) n (%)
Present (n = 216) n (%) Absent (n = 282) n (%)
Age group (years)
≤ 10
11 - 20
21 - 30
31 - 40
41 - 50
51 - 60
61 - 70
71 - 80
2 (0.4)
40 (8.1)
54 (10.8)
24 (4.8)
26 (5.2)
25 (5.0)
14 (2.8)
31 (6.2)
15 (3.0)
31 (6.2)
44 (8.8)
45 (9.0)
53 (10.6)
40 (8.0)
32 (6.4)
22 (4.4)
17 (3.4)
71 (14.3)
98 (19.6)
69 (13.8)
79 (15.8)
65 (13.0)
46 (9.2)
53 (10.6)
Sex
Male
Female
86 (17.3)
130 (26.1)
59 (11.9)
223 (44.7)
145 (29.1)
353 (70.8)
Socio-economic status
Low
Middle
High
146 (29.3)
48 (9.6)
22 (4.4)
183 (36.7)
75 (15.1)
24 (4.8)
329 (66.1)
123 (24.7)
46 (9.2)
Type of Hearing impairment
Conductive
Sensorineural
Mixed
Degree of Affectation
Right Ear
Left Ear
Other symptoms**
Ear ache
Ear discharge
Tinnitus
Vertigo
Sensation of fullness in ear
 2 (0.5)
195 (39.1)
19 (3.8)
7 (15.5)
139 (27.9)
12 (2.4)
141 (28.3)
45 (9.1)
7 (1.4)
21 (4.2)
61 (12.2)
197 (39.6)
24 (4.8)
20 (4.0)
262 (52.6)
47 (9.4)
197 (39.5)
26 (5.2)
7 (1.8)
94 (18.9)
63 (12.7)
392 (78.7)
43 (8.6)
97 (19.5)
401 (80.5)
59 (11.8)
338 (67.8)
71 (14.3)
14 (2.8)
115 (23.1)
**Some had more than one symptoms

Table 2: Hearing threshold of the patients with disabling hearing loss.

Variable

 

Degree of hearing impairment
Mild
n (%)
Moderate
n (%)
Moderately severe n (%) Severe
n (%)
Profound
n (%)
TOTAL
n (%)
Age
Children 2 (0.9) 5 (2.3) 8 (3.7) 5 (2.3) 4 (1.9) 24 (11.1)
Adults 0 (0) 79 (36.6)  44 (20.3) 57 (26.4)  12 (5.6) 192 (88.9)
Sex
Male 0 (0) 35 (16.2) 28 (12.9) 19 (8.8) 4 (1.9) 86 (39.8)
Female 2 (0.9) 49 (22.7) 24 (11.1) 43 (19 .9) 12 (5.6) 130 (60.2)
TOTAL 2 (0.9) 84 (38.9) 52 (24.1) 62 (28.7) 16 (7.4) 216 (100)

The risk factors for hearing loss were identified in 155 (71.8%) patients with disabling hearing; of which chronic suppurative otitis media is a major factor in this study (Table 3).

Table 3: Distribution of factors for disabling hearing loss among patients.
Infective factors
 n = 89 (100%)  
 Factors Total n (%)
Chronic suppurative otitis media 59 (66.3)
Meningitis 11 (12.4)
Measles 8 (9.0)
HIV/AIDS 5 (5.6)
Varicella zoster infection 4 (4.5)
Mumps 2 (2.2)
Non-Infective factors
n = 66 (100%)
  Presbyacusis 11 (16.7)
  Neonatal jaundice  8 (12.1)
  Noise induced  7 (10.6)
  Birth asphyxia  6 (9.1)
  Cerebrovascular accident(Stroke)  6 (9.1)
  Ototoxicity  7 (10.6)
155 patients had risk factors for disabling hearing loss.

Only 35 (16.2%) patients with disabling hearing loss had medical or surgical treatment and hearing rehabilitative measures; 23 (10.1%) of whom had some improvement in hearing threshold at 6months after intervention. The rehabilitation outcomes were not excellent but still commendable as shown in table 4. Hearing aids were recommended for amplification in 12 (5.5%) patients, but only 3 (1.4%) of them could procure the device due to financial constraints. Also the devices were procured in another center which is hundreds of kilometers away due to non-availability of these services in our center.

Table 4: Therapeutic care and management outcomes of patients with disabling hearing loss
Management Number of patients n (%) Mean Hearing level before management (dB) Mean Hearing level post management (dB) Mean hearing threshold gain (dB) Clinical result
Hearing aid  3 (8.6) 58 ± 0.1 32 ± 5.4 25 ± 0.8 Improvement in hearing level
Medication/ topical ear dressing for CSOM 17 (48.6) 53 ± 2.8 39 ± 0.2 14 ± 0.2 Healed with neo-membrane formation
Improvement in hearing level
Medication and topical ear dressing for CSOM 12 (34.3) 59 ± 1.4 59 ± 1.7 0 Eradication of the disease but with persistent tympanic membrane perforation
No improvement in hearing level
Myringoplasty  1 (2.8) 45 38 7 Neomembrane formation
Improvement in hearing level
Tympanomastoidectomy  2 (5.7) 63.4 53.8 9.6 Extirpation of the disease and neomembrane formation
Improvement in hearing level
Total 35 (100)        
*CSOM - Chronic suppurative otitis media. Only 35 (16.2%) had rehabilitation out of the 216 patients with disabling hearing loss of which 23 (10.1%) had some improvement in hearing threshold at 6 month after intervention.

Ear surgeries were suggested to 32 (14.8%) patients, of whom 29 (13.4%) patients declined due to the cost of surgery. Hearing threshold improved marginally with eradication of middle ear disease in some patients, while hearing loss persisted as shown in (Table 4). All the patients with disabling hearing loss were educated on the risk factors for hearing loss and measures to prevent deterioration of the residual hearing.

Over 5% of the world’s population has disabling hearing loss with significant impact on daily activities, causing isolation and feelings of loneliness [2,6]. The prevalence of disabling hearing loss in this study was 43.4%. This high prevalence may be due to the fact that it is a hospital-based study, unlike 5.2% prevalence reported in a community study in Brazil. This high proportion of disabling hearing loss in this study may affect the social and economic development of the community and the country negatively [26]. In this study, disabling hearing loss increases with age, similar to previous studies [9,27,28]. This may be due to the decline in serum aldosterone levels with increase in age, with consequent loss of its protective effect on auditory pathways [29]. In this study, disabling hearing loss was preponderant among females, unlike previous studies [27,28]. Though females have protective effect of estrogen hormone on their hearing [30], it has been demonstrated in animal and human research that unnatural levels of progesterone may be harmful to hearing in females [31,32]. However this study did not determine the use of progesterone hormonal agents for birth control or therapeutic use among the patients, further study is required to determine this possibility. The principal factor for disabling hearing loss was chronic suppurative otitis media similar to previous studies in developing countries [33,34]. Poor hygiene, gastroesophageal reflux disease, and dysfunctional immune system are predisposing factors for suppurative otitis media [35].

Despite the benefits of hearing aids to enhancing speech comprehension and effective communication, its usage was hampered by cost and non-availability in this study. Similar to previous reports that hearing rehabilitation is hindered by the high cost and non-availability of hearing aid devices [23,24]. This gap can be bridged through improved funding of health sector and exploring low-cost interventions for low income countries to meet the demand for hearing aids. The average cost of hearing aids in Nigeria is beyond the reach of the general populace [36]. This is due to poor economy in a country with monthly minimum wage of 18,000 Naira ($51.4 USD) and the cost of hearing aid is 125,000 Naira ($357). Less than 1% of hearing impaired individuals in developing countries use hearing aids due to the high cost of the device [37,38]. Although, hearing-aid enhances hearing, its usage, however, is facilitated by self-perceived hearing difficulty and not the degree or severity of the hearing loss [37]. Lack of funds debars patients from surgical procedures, since cost of health care is paid out of pocket by the patients. This can be prevented by ensuring health insurance scheme for all the populace. The rehabilitation of patients with hearing loss is poor in this study, though management outcome of the few rehabilitated patients was good with improvement in hearing threshold, in spite of the limited resources.

Regardless of the fact that certain cases of hearing loss are preventable, hearing loss still abounds in resource challenged settings like Nigeria [39,40]. Hearing loss due to infections are preventable by good healthy ear-care practices, immunisation against childhood diseases (measles, meningitis, rubella, and mumps), early detection of hearing loss, and initiating appropriate medical care, which is economical than rehabilitative measures [2]. This can be achieved through health education, public awareness and by incorporating ear-care into primary health care system.

Disabling hearing loss is high among patients presenting with hearing loss. There is a need for the introduction of inexpensive and sustainable aural rehabilitation services in developing countries in spite of limited resource. Health education and early intervention will reduce preventable hearing loss.

This is a retrospective study which will account for lack of details on patients’ information. It is a hospital-based study from one geopolitical part of a country and not a population based data, thus it might not adequately represent the occurrence of hearing loss and challenges in hearing rehabilitation among the populace. In spite of these limitations this study gives us an idea about hearing problems in Nigeria, and the need for resources in the health care system to address the problems.

  1. Turner JS, Per-Lee JH. Auditory Dysfunction: Hearing Loss. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990.
  2. Olusanya BO, Neumman KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014; 92: 367-373. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24839326
  3. WHO. International Classification of Functioning, Disability and Health (ICF). Geneva: World Health Organization; 2001.
  4. World Health Organization. Prevention of blindness and deafness. Grades of hearing impairment [Internet]. Geneva: World Health Organization; 2013.
  5. Steel KP. Science, medicine, and the future: new interventions in hearing impairment. BMJ. 2000; 320: 622-625. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/10698884
  6. World Health Organization. Deafness and hearing loss. 2018.
  7. Geneva: World Health Organization. Global costs of unaddressed hearing loss and cost-effectiveness of interventions. 2018.
  8. Mahboubi H, Oliaei S, Kiumehr S, Dwabe S, Djalilian HR. The prevalence and characteristics of tinnitus in the youth population of the United States. Laryngoscope. 2013; 123: 2001-2008. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23606449
  9. Oishi N, Schacht J. Emerging treatments for noise-induced hearing loss. Expert Opin Emerg Drugs. 2011; 16: 235–245. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21247358
  10. Youth population of the United States. Laryngoscope. 2013; 123: 2001-2008.
  11. Basner M, Babisch W, Davis A, Brink M, Clark C, et al. Auditory and non-auditory effects of noise on health. Lancet. 2014; 383: 1325-1332. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24183105
  12. Ganesan P, Schmiedge J, Manchaiah V, Swapna S, Dhandayutham S, Kothandaraman PP. Ototoxicity: A Challenge in Diagnosis and Treatment. J Audiol Otol. 2018; 22: 59-68. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29471610
  13. Wilson BS, Tucci DL, Merson MH, O'Donoghue GM. Global hearing health care: new findings and perspectives. Lancet. 2017; 390: 2503-2515. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28705460
  14. Zhan W, Cruickshanks KJ, Klein BE, Klein R, Huang GH, et al. Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol. 2010; 171: 260-266. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20008889
  15. Olusanya BO, Swanepoel de W, Chapchap MJ, Castillo S, Habib H, et al. Progress towards early Detection services for infants with hearing loss in developing countries. BMC Health Serv Res. 2007; 7: 14. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17266763
  16. Committee on Infant Hearing. Year 2007 Position Statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007; 120: 898-921. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17908777
  17. Mc Gavin ZA, Wagner AL, Carlson BF, Power LE. Eboreime E, et al. Childhood full and under-vaccination in Nigeria 2013. 2018: 36: 7294-7299. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30340882
  18. Babalola S. Determinants of the Uptake of the Full Dose of Diphtheria–Pertussis–Tetanus Vaccines (DPT3) in Northern Nigeria: A Multilevel Analysis. Matern Child Health J. 2009; 13: 550-558. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18607704
  19. WHO. Prevention of blindness and deafness. 2018.
  20. Rodenburg V, Ruytjens L, Oostenbrink R, Van der Schroeff MP. Repeated Audiometry After Bacterial Meningitis: Consequences for Future Management. Otol Neurotol. 2018; 39: 301-306. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29659414
  21. Kotby MN, Tawfik S, Aziz A, Taha H. Public health impact of hearing impairment and disability. Folia Phoniatr Logop. 2008; 60: 58-63. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18235192
  22. Stevens G, Flaxman S, Brunskill E, Mascarenhas M, Mathers CD, et al. Global Burden of Disease Hearing Loss Expert Group: Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health. 2013; 23: 146-152. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22197756
  23. Lederberg AR, Schick B, Spencer PE. Language and literacy development of deaf and hard-of-hearing children: Successes and challenges. Developmental Psychology. 2013; 49: 15-30. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22845829
  24. World Health Organization. Preferred profile for hearing-aid technology suitable for low- and middle-income countries. 2017.
  25. Laplante LA, Hickson L, Worrall L. Rehabilitation of Older Adults with Hearing Impairment: A Critical Review. J Aging Health. 2010; 22: 143-153. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20056812
  26. Cahart R. Classifying Audiolograms: An approved method of classifying. Laryngoscope. 1945; 55: 1-3.
  27. Nash SD, Cruickshanks KJ, Klein R, Klein BE, Nieto FJ, et al. The prevalence of hearing impairment and associated risk factors: The Beaver Dam offspring study. Arch Otolaryngol Head Neck Surg. 2011; 137: 432-439. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21339392
  28. Islam MS, Islam R, Bhuiyan MA, Rashid S, Datta PG. Pattern and degree of hearing loss in chronic suppurative otitis media. Bangladesh Journal of Otorhinolaryngology. 2010; 16: 96-105.
  29. Tadros SF, Frisina ST, Mapes F, Frisina DR, Frisina RD. High serum aldosterone levels correlate with lower hearing thresholds in aged humans: a possible protective hormone against presbycusis. Hear Res. 2005; 209: 10-18.
  30. Souza DDS, Luckwu B, Andrade WTL, Pessoa LSF, Nascimento JAD, et al. Variation in the Hearing Threshold in Women during the Menstrual Cycle. Int Arch Otorhinolaryngol. 2017; 21: 323-328. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29018493
  31. Guimaraes P, Frisina ST, Mapes F, Tadros SF, Frisina DR, et al. Progestin negatively affects hearing in aged women. Proc Natl Acad Sci USA. 2006; 103: 14246-1429. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16959884
  32. Price K, Zhu X, Guimaraes PF, Vasilyeva ON, Frisina RD. Hormone replacement therapy diminishes hearing in peri-menopausal mice. Hear Res. 2009; 252: 29-36. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19269311
  33. Ramon GJ, Anders K, Preben H. The risk of hearing loss in a population with a high prevalence of chronic suppurative otitis media. Int J Pediatr Otorhinolaryngol. 2013; 77: 1530-1535. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23906989
  34. Kolo ES, Salisu AD, Yaro AM, Nwaorgu OG. Sensorineural hearing loss in patients with chronic suppurative otitis media. Indian J Otolaryngol Head Neck Surg. 2011; 64: 59-62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23449378
  35. Park M, Lee JS, Lee JH, Oh SH, Park MK. Prevalence and risk factors of chronic otitis media: the Korean National Health and Nutrition Examination Survey 2010-2012. PLoS One. 2015; 10: e0125905. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25978376
  36. Adeyi A, Tonga N, Olugbenga S. Chronic suppurative otitis media: Socio-economic implications in a tertiary hospital in Northern Nigeria. Pan Afr Med J. 2010; 4: 3. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21119988
  37. Fischer ME, Cruickshanks KJ, Wiley TL, Klein BE, Klein R, et al. Determinants of hearing aid acquisition in older adults. Am J Public Health. 2011; 101: 1449-1455. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21680930
  38. Meyer C and Hickson L. What factors influence help-seeking for hearing impairment and hearing aid adoption in older adults. Int J Audiol. 2012; 51: 66-74. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22256793
  39. Primary care and training resource: advanced level Geneva: World Health Organization; 2006.
  40. Sogebi OA. Assessment of the risk factors for hearing loss in adult Nigerian population. Niger Med J. 2013; 54: 244-249. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24249950